DekaBank Deutsche Girozentrale Buys Shares of 15,000 Dyne Therapeutics, Inc. (NASDAQ:DYN)

DekaBank Deutsche Girozentrale bought a new stake in shares of Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Rating) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 15,000 shares of the company’s stock, valued at approximately $171,000. Other large investors have also recently bought […]

Related Keywords

United States ,Raymond James ,Dekabank Deutsche Girozentrale ,Tower Research Capital ,Dyne Therapeutics Company Profile ,Nasdaq ,Denali Advisors ,Group Plc ,Dyne Therapeutics Inc ,Dyne Therapeutics ,Get Rating ,General Group Plc ,Research Capital ,Visit Holdingschannel ,Dyne Therapeutics Daily ,Nasdaq Dyn ,Ladyn ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,